Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $124.27 million. The enterprise value is $138.23 million.
| Market Cap | 124.27M |
| Enterprise Value | 138.23M |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 42.12 million shares outstanding. The number of shares has increased by 7.49% in one year.
| Current Share Class | 42.12M |
| Shares Outstanding | 42.12M |
| Shares Change (YoY) | +7.49% |
| Shares Change (QoQ) | +1.77% |
| Owned by Insiders (%) | 13.56% |
| Owned by Institutions (%) | 39.44% |
| Float | 30.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.10 |
| Forward PS | 1.98 |
| PB Ratio | 12.82 |
| P/TBV Ratio | 12.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.95, with a Debt / Equity ratio of 3.96.
| Current Ratio | 4.95 |
| Quick Ratio | 3.74 |
| Debt / Equity | 3.96 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.59 |
Financial Efficiency
Return on equity (ROE) is -102.51% and return on invested capital (ROIC) is -4.31%.
| Return on Equity (ROE) | -102.51% |
| Return on Assets (ROA) | -3.44% |
| Return on Invested Capital (ROIC) | -4.31% |
| Return on Capital Employed (ROCE) | -6.45% |
| Weighted Average Cost of Capital (WACC) | 12.00% |
| Revenue Per Employee | $290,576 |
| Profits Per Employee | -$41,146 |
| Employee Count | 205 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 2.06 |
Taxes
In the past 12 months, Apyx Medical has paid $477,000 in taxes.
| Income Tax | 477,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.77% in the last 52 weeks. The beta is 1.46, so Apyx Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -23.77% |
| 50-Day Moving Average | 2.74 |
| 200-Day Moving Average | 3.57 |
| Relative Strength Index (RSI) | 61.34 |
| Average Volume (20 Days) | 164,525 |
Short Selling Information
The latest short interest is 213,730, so 0.51% of the outstanding shares have been sold short.
| Short Interest | 213,730 |
| Short Previous Month | 206,825 |
| Short % of Shares Out | 0.51% |
| Short % of Float | 0.70% |
| Short Ratio (days to cover) | 1.39 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $59.57 million and -$8.44 million in losses. Loss per share was -$0.19.
| Revenue | 59.57M |
| Gross Profit | 37.80M |
| Operating Income | -3.28M |
| Pretax Income | -7.78M |
| Net Income | -8.44M |
| EBITDA | -2.47M |
| EBIT | -3.28M |
| Loss Per Share | -$0.19 |
Balance Sheet
The company has $25.78 million in cash and $39.75 million in debt, with a net cash position of -$13.97 million or -$0.33 per share.
| Cash & Cash Equivalents | 25.78M |
| Total Debt | 39.75M |
| Net Cash | -13.97M |
| Net Cash Per Share | -$0.33 |
| Equity (Book Value) | 10.04M |
| Book Value Per Share | 0.23 |
| Working Capital | 42.97M |
Cash Flow
In the last 12 months, operating cash flow was -$8.23 million and capital expenditures -$666,000, giving a free cash flow of -$8.89 million.
| Operating Cash Flow | -8.23M |
| Capital Expenditures | -666,000 |
| Depreciation & Amortization | 806,000 |
| Net Borrowing | -21,000 |
| Free Cash Flow | -8.89M |
| FCF Per Share | -$0.21 |
Margins
Gross margin is 63.45%, with operating and profit margins of -5.50% and -14.16%.
| Gross Margin | 63.45% |
| Operating Margin | -5.50% |
| Pretax Margin | -13.07% |
| Profit Margin | -14.16% |
| EBITDA Margin | -4.15% |
| EBIT Margin | -5.50% |
| FCF Margin | n/a |
Dividends & Yields
Apyx Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -7.49% |
| Shareholder Yield | -7.49% |
| Earnings Yield | -6.56% |
| FCF Yield | -7.11% |
Analyst Forecast
The average price target for Apyx Medical is $6.50, which is 120.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.50 |
| Price Target Difference | 120.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 13.10% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on January 6, 1994. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jan 6, 1994 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |